Abstract
Mental and neurological conditions have been linked to structural brain variations. However, aside from dementia, the value of brain structural characteristics derived from brain scans for prediction is relatively low. One reason for this limitation is the clinical and biological heterogeneity inherent to such conditions. Recent studies have implicated aberrations in the cerebellum, a relatively understudied brain region, in these clinical conditions. Here, we used machine learning to test the value of individual deviations from normative cerebellar development across the lifespan (based on trained data from >27k participants) for prediction of autism spectrum disorder (ASD) (n=317), bipolar disorder (BD) (n=238), schizophrenia (SZ) (n=195), mild cognitive impairment (MCI) (n=122), and Alzheimer's disease (AD) (n=116). We applied several atlases and derived median, variance, and percentages of extreme deviations within each region of interest. Our results show that lobular and voxel-wise cerebellar data can be used to discriminate healthy controls from ASD and SZ with moderate accuracy (the area under the receiver operating characteristic curves ranged from 0.56 to 0.64), The strongest contributions to these predictive models were from posterior regions of the cerebellum, which are more strongly linked to higher cognitive functions than to motor control.
Competing Interest Statement
O.A.A. has received speaker fees from Lundbeck, Janssen, Otsuka, and Sunovion and is a consultant to Cortechs.ai and Precision-Health.ai. E.H.L. has received speaker fees from Lundbeck, and is the CTO and shareholder of baba.vision. L.T.W. and T.W. are shareholders of baba.vision. KP contributed to clinical trials for Roche (BN29553) and Novo Nordisk (NN6535-4730), outside the submitted work. The other authors report no competing interests.
Funding Statement
The work was supported by the South-Eastern Norway Regional Health Authority (2021040, supporting M.K. & T.M. 2018037, 2018076, 2019101, 2021070, 2023012, 500189), DFG Emmy Noether 513851350 (supporting T.W.), NordForsk (#164218), the Research Council of Norway (249795, 248238, 276082, 286838, 288083, 323951, 324499), Stiftelsen Kristian Gerhard Jebsen, ERA-Net Cofund through the ERA PerMed project IMPLEMENT, and the European Research Council under the European Unions Horizon 2020 research and Innovation program (ERC StG Grant No. 802998). A.F.M gratefully acknowledges funding from the European Research Council (MENTALPRECISION 101001118) and from the Raynor Foundation. The funders had no role in conception of the study as well as the analyses and/or interpretations of the results.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
These are analyses of publicly and privately available data. Description of informed consent and other ethical procedures is extensively described in each study, referenced in the manuscript. The data were stored and analyzed using University of Oslos secure platform, Services for sensitive data (TSD), in compliance with Norwegian privacy regulations.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
In this study, we used brain imaging from ABIDE, ADNI, AIBL, DEMGEN, and TOP. The cerebellar normative models from this work are available on via PCNportal (76): https://pcnportal.dccn.nl/.
